← Leaderboards
Karen Conneely
Emory University
$2,156,861
Attributed
$4,645,004
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,645,004 · 3
By mechanism
R01$3,651,155 · 2
U34$993,849 · 1
Top collaborators
- Alicia K Smith4 shared
- Andrea Baccarelli3 shared
- Joanne M Murabito3 shared
- Pradeep Natarajan3 shared
Most similar at Emory University
Same institution · by research overlap
- Michele Marcus$10,807,435
- Alicia K Smith$7,736,345
- Jeremy M. Boss$41,716,661
- Monica Uddin$3,666,268
- Kim Wallen$8,535,143
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortDna MethylationEpigenetic ProcessLinkEpigenomeMethylationPhenotypePredispositionEnsureDesignGenome Wide Association StudyEpigenomicsMediatingMemberBiologicalCardiovascular DiseasesBaseCell TypeData SetDisorder RiskGenesPatternGenome-WideSite
Grant awards (10)
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed$645,578
R01 · FY2025 · HL · contact PI
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed$624,385
R01 · FY2024 · HL · contact PI
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed$662,051
R01 · FY2023 · HL · contact PI
Genetic Biomarkers of Polybrominated Biphenyl (PBB)$315,308
R01 · FY2018 · ES
Genetic Biomarkers of Polybrominated Biphenyl (PBB)$438,285
R01 · FY2017 · ES
Genetic Biomarkers of Polybrominated Biphenyl (PBB)$482,774
R01 · FY2016 · ES
Identifying epigenetic mechanisms underlying age-related disease risk in CHARGE$456,718
U34 · FY2016 · AG
Identifying epigenetic mechanisms underlying age-related disease risk in CHARGE$17,760
U34 · FY2016 · AG
Identifying epigenetic mechanisms underlying age-related disease risk in CHARGE$519,371
U34 · FY2015 · AG
Genetic Biomarkers of Polybrominated Biphenyl (PBB)$482,774
R01 · FY2015 · ES